CatherineVan PoznakMD

Oncology • Ann Arbor, MI

Breast Cancer, Hematologic Oncology

Associate Professor

Join to view full profile

Dr. Van Poznak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Van Poznak's full profile

Already have an account?

Office
1500 East Medical Center Dr
B1 floor Cancer Geriatrics CTR Recp C
Ann Arbor, MI 48109
Phone+1 734-936-6000

Fax+1 734-215-2109

Summary

Dr. Catherine Van Poznak is an oncologist at the University of Michigan in Ann Arbor, MI. She received her medical degree from Weill Cornell Medical College of Cornell University and has been in practice 21 years. She specializes in breast cancer.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1995 - 1996
Weill Cornell MedicineClass of 1995

Certifications & Licensure

MI State Medical License 2006 - 2026
NY State Medical License 1996 - 2023
PA State Medical License 1995 - 1996
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

20 citations
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
Ghada El-Hajj Fuleihan, Gregory A Clines, Mimi I Hu, Claudio Marcocci, M Hassan Murad
The Journal of Clinical Endocrinology and Metabolism. 2023-02-15
42 citations
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Andrea Eisen, Mark R Somerfield, Melissa K Accordino, Phillip S Blanchette, Mark J Clemons
Journal of Clinical Oncology. 2022-03-01
3 citations
Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis...
Aya Bassatne, Abir Bou Khalil, Marlene Chakhtoura, Asma Arabi, Catherine Van Poznak
Metabolism. 2022-03-01

Lectures

Bone Disease in Breast Cancer
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018

Committees

Co-chair, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present